April 8, 2026 8:55 PM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

Tilray

Cannabis Latest 

Tilray Brands Sees Fourth Quarter Impacted By Massive Impairments, Negative Gross Profit

July 28, 2022 8:18 AMJuly 28, 2022 8:19 AM Jay Lutz 0 Comments Tilray

Tilray Brands (TSX: TLRY) this morning reported its fourth quarter and full year fiscal 2022 financial results. The results were

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray: Haywood Slashes Price Target From $7.25 To $4.00

July 13, 2022 2:54 PMJuly 13, 2022 2:15 PM Justin Young 0 Comments Analyst Estimate, Tilray

Tilray Brands (TSX: TLRY) is expected to report its fiscal fourth-quarter results on July 26th. The consensus revenue estimate is

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray: Canaccord Lowers Target On Expected Adult-Use Sales Slump, Revised Hexo Deal

June 17, 2022 10:49 AMJune 17, 2022 10:49 AM Justin Young 0 Comments Analyst Estimate, Tilray

Earlier this week, Tilray Brands (TSX: TLRY) announced an update to their strategic alliance with Hexo Corp (TSX: HEXO) as

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray May Own Up To 50% Of Hexo Under Revised Debt Deal

June 14, 2022 8:55 AMJune 14, 2022 8:55 AM Jay Lutz 0 Comments Hexo Corp, Tilray

It appears that Tilray Brands (TSX: TLRY) may ultimately end up with a larger stake in Hexo Corp (TSX: HEXO)

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray Brands Attempted To Buy Hexo For Up To $3 Per Share In November – But Was Rejected

May 17, 2022 7:38 AMMay 17, 2022 7:38 AM Jay Lutz 0 Comments Hexo Corp, Tilray

Yesterday, Hexo Corp (TSX: HEXO) filed a management information circular related to the arrangement entered into with Tilray Brands (TSX:

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Hexo Announces US$40 Million ATM Financing, Has Less Than Two Months Cash Remaining

May 3, 2022 10:48 AMMay 3, 2022 10:48 AM Jay Lutz 0 Comments Hexo Corp, Tilray

Hexo Corp (TSX: HEXO) is looking to dilute its current shareholders once again. The firm this morning announced the launch

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray Brands Enters Definitive Agreement With Hexo Corp, To Acquire Up To US$193 Million In Debt

April 12, 2022 8:48 AMApril 12, 2022 8:48 AM Jay Lutz 0 Comments Hexo Corp, Tilray

Tilray Brands (TSX: TLRY) has finally come to a definitive agreement with that of Hexo Corp (TSX: HEXO) as it

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray Sees Jefferies Lower Target Due To Canadian Cannabis Headwinds

April 10, 2022 1:03 PMApril 10, 2022 12:34 PM Justin Young 0 Comments Analyst Estimate, Tilray

Jefferies lowered their price target on Tilray Brands (TSX: TLRY), after updating their outlook, saying excluding all the Canadian headwinds,

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Tilray Sees Revenue Decline On A Sequential Basis In Third Quarter

April 6, 2022 7:58 AMApril 6, 2022 7:58 AM Jay Lutz 0 Comments Tilray

Tilray Brands (TSX: TLRY) this morning posted its third quarter financial results. Despite much blustering within the associated news release,

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Hexo Corp Defaults On Secured Convertible Debt, Lender Waives Event Due To Tilray Deal

March 14, 2022 7:38 AMMarch 14, 2022 7:38 AM Jay Lutz 0 Comments Hexo Corp, Tilray

The inevitable has finally happened. Hexo Corp (TSX: HEXO) this morning formally indicated that it has defaulted on its outstanding

Share
Tweet
Share
Reddit
Read more
  • ← Previous
  • Next →

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Palantir Sees 30% Revenue Jump in Q3 2024, Raises Revenue Guidance Again
  • Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
  • "Run For Your Life": Ex-Employees Bare Aritzia's Discriminatory And Exploitative Culture
  • Missouri Cannabis Sales Rake in $240 Million in New Tax Revenue Over Past Year
  • Gary Ng Charges Bring More Questions Than Answers

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.